Confirmed Activity and Tolerability of Weekly Paclitaxel in the Treatment of Advanced Angiosarcoma

Background. In several prospective and retrospective studies, weekly paclitaxel showed promising activity in patients with angiosarcoma. Patients and Methods. Our study was originally designed as a prospective, phase II multicenter trial for patients younger than 75, with ECOG performance status 0–2...

Full description

Saved in:
Bibliographic Details
Published in:Sarcoma
Main Authors: Apice, Gaetano, Pizzolorusso, Antonio, Di Maio, Massimo, Grignani, Giovanni, Gebbia, Vittorio, Buonadonna, Angela, De Chiara, Annarosaria, Fazioli, Flavio, De Palma, Giampaolo, Galizia, Danilo, Arcara, Carlo, Mozzillo, Nicola, Perrone, Francesco
Format: Artigo
Language:Inglês
Published: Hindawi Publishing Corporation 2016
Subjects:
Clinical Study
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4785388/
https://ncbi.nlm.nih.gov/pubmed/27019606
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/6862090
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items